Edwards Lifesciences CorporationEWNYSE
LOADING
|||
Revenue Performance
Above historical average, modest growth trend.
Left:
||||
Total revenue from sales of goods and services
Latest
$5.44B
↑ 28% above average
Average (9y)
$4.24B
Historical baseline
Range
High:$5.44B
Low:$2.49B
CAGR
+9.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $5.44B | +8.6% |
| 2023 | $5.01B | -6.9% |
| 2022 | $5.38B | +2.9% |
| 2021 | $5.23B | +19.3% |
| 2020 | $4.39B | +0.9% |
| 2019 | $4.35B | +16.8% |
| 2018 | $3.72B | +8.4% |
| 2017 | $3.44B | +15.9% |
| 2016 | $2.96B | +18.8% |
| 2015 | $2.49B | - |